Skip to main content
. 2019 Jul 4;12:68. doi: 10.1186/s13045-019-0751-4

Table 4.

Treatment of relapse after haplo-SCT

graphic file with name 13045_2019_751_Tab4_HTML.jpg

ALL acute lymphoblastic leukemia, AML acute myeloid leukemia, SCT stem cell transplant, TKI tyrosine kinase inhibitors, DLI donor lymphocyte infusion